These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34628665)
1. Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations. Campbell K; Bridge JA; DiMaio D; Wilson J; Shalin SC; Gardner JM J Cutan Pathol; 2022 Mar; 49(3):274-277. PubMed ID: 34628665 [TBL] [Abstract][Full Text] [Related]
2. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report. Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767 [TBL] [Abstract][Full Text] [Related]
4. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions. Dadone-Montaudié B; Alberti L; Duc A; Delespaul L; Lesluyes T; Pérot G; Lançon A; Paindavoine S; Di Mauro I; Blay JY; de la Fouchardière A; Chibon F; Karanian M; MacGrogan G; Kubiniek V; Keslair F; Cardot-Leccia N; Michot A; Perrin V; Zekri Y; Coindre JM; Tirode F; Pedeutour F; Ranchère-Vince D; Le Loarer F; Pissaloux D Mod Pathol; 2018 Nov; 31(11):1683-1693. PubMed ID: 29955147 [TBL] [Abstract][Full Text] [Related]
5. Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions. Lee PH; Huang SC; Wu PS; Tai HC; Lee CH; Lee JC; Kao YC; Tsai JW; Hsieh TH; Li CF; Li WS; Liu TT; Su YL; Yu SC; Huang HY Am J Surg Pathol; 2022 Jul; 46(7):942-955. PubMed ID: 35034038 [TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782 [TBL] [Abstract][Full Text] [Related]
7. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications. Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652 [TBL] [Abstract][Full Text] [Related]
8. Platelet-Derived Growth Factor-D Fusion-Positive Dermatofibrosarcoma Protuberans: Case Report of an Atypical Breast Mass and Literature Review. Chandler B; Jing F; David MP; Nazarullah A Int J Surg Pathol; 2023 Dec; 31(8):1610-1617. PubMed ID: 37016743 [TBL] [Abstract][Full Text] [Related]
10. Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Abbott JJ; Erickson-Johnson M; Wang X; Nascimento AG; Oliveira AM Mod Pathol; 2006 Nov; 19(11):1512-8. PubMed ID: 16980946 [TBL] [Abstract][Full Text] [Related]
11. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants. Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881 [TBL] [Abstract][Full Text] [Related]
12. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans. Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334 [TBL] [Abstract][Full Text] [Related]
13. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681 [TBL] [Abstract][Full Text] [Related]
14. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion. Bianchini L; Maire G; Guillot B; Joujoux JM; Follana P; Simon MP; Coindre JM; Pedeutour F Virchows Arch; 2008 Jun; 452(6):689-96. PubMed ID: 18253748 [TBL] [Abstract][Full Text] [Related]
15. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans. Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935 [TBL] [Abstract][Full Text] [Related]
16. A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences. Gisselsson D; Höglund M; O'Brien KP; Dumanski JP; Mertens F; Mandahl N Cancer Lett; 1998 Nov; 133(2):129-34. PubMed ID: 10072161 [TBL] [Abstract][Full Text] [Related]
17. Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion. Lu Y; Li T; Chen M; Peng H; Du T; Qiu Y; Zhang H Virchows Arch; 2022 Aug; 481(2):313-319. PubMed ID: 35171326 [TBL] [Abstract][Full Text] [Related]
18. [Cryptic COL1A1-PDGFB fusion in dermatofibrosarcoma protuberans: a clinicopathological and genetic analysis]. Chen M; Chen YM; Lu Y; He X; Peng H; Zhang HY Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):13-18. PubMed ID: 36617900 [No Abstract] [Full Text] [Related]
19. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation. Swaby MG; Evans HL; Fletcher CD; Prieto VG; Patel KU; Lev DC; Lòpez-Terrada D; Lazar AJ; Wang WL Am J Dermatopathol; 2011 Jun; 33(4):354-60. PubMed ID: 21478726 [TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors. Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]